Development of an Allogeneic Universally Tolerated NKT Cell Platform for Off-the-Shelf Cancer Immunotherapy

被引:0
|
作者
Jin, Jingling [1 ]
Liu, Bin [1 ]
Guo, Linjie [1 ]
Di Pierro, Erica J. [1 ]
Balzeau, Julien [1 ]
Courtney, Amy [1 ]
Ngai, Ho [1 ]
Metelitsa, Leonid S. [1 ]
机构
[1] Baylor Coll Med, Houston, TX 77030 USA
关键词
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
682
引用
收藏
页码:321 / 321
页数:1
相关论文
共 50 条
  • [11] OFF-THE-SHELF TUMOR IMMUNOTHERAPY WITH GENETICALLY ENHANCED ALLOGENEIC T-CELL PRECURSORS
    Zakrzewski, J. L.
    Suh, D.
    Markley, J. C.
    Smith, O. M.
    King, C.
    Goldberg, G.
    Jenq, R.
    Holland, A. M.
    Grubin, J.
    Cabrera-Perez, J.
    Lu, S. X.
    Rizzuto, G.
    Sant'Angelo, D. B.
    Riviere, I
    Sadelain, M.
    Zuniga-Pflucker, J. C.
    van den Brink, M. R. M.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (02) : 126 - 126
  • [12] DEVELOPMENT OF POTENT IPSC-DERIVED MACROPHAGES (IMACS) FOR OFF-THE-SHELF CANCER IMMUNOTHERAPY - A NEW CELL TYPE IN THE EVOCELLS PLATFORM
    Haake, Kathrin
    Mirenda, Michela
    Bousquet, Julien
    Scheinpflug, Philine
    Esquerre, Michael
    Holtzinger, Audrey
    Pfaender, Stefanie
    Paillasse, Michael
    Sommermeyer, Daniel
    Bombarde, Oriane
    Ysebaert, Loic
    Despas, Fabien
    Austen, Matthias
    Scheel, Andreas
    Dangl, Markus
    Braun, Monika
    Wagner, Nadja
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A355 - A355
  • [13] Toward a personalized off-the-shelf cellular immunotherapy for cancer
    Williams, William V.
    Lacher, Markus D.
    Sunkari, Vivek G.
    Wiseman, Charles
    Lopez-Lago, Miguel
    CANCER RESEARCH, 2022, 82 (12)
  • [14] OFF-THE-SHELF CAR T CELL IMMUNOTHERAPY FOR GLIOBLASTOMA
    Martins, P.
    D'Souza, R.
    Smith, C.
    Day, B.
    Khanna, R.
    CYTOTHERAPY, 2023, 25 (06) : S238 - S238
  • [15] Toward the development of true "off-the-shelf" synthetic T-cell immunotherapy
    Iriguchi, Shoichi
    Kaneko, Shin
    CANCER SCIENCE, 2019, 110 (01): : 16 - 22
  • [16] Generating allogeneic CAR-NKT cells for off-the-shelf cancer immunotherapy with genetically engineered HSP cells and feeder-free differentiation culture
    Li, Yan-Ruide
    Zhou, Kuangyi
    Lee, Derek
    Zhu, Yichen
    Halladay, Tyler
    Yu, Jiaji
    Zhou, Yang
    Lyu, Zibai
    Fang, Ying
    Chen, Yuning
    Semaan, Sasha
    Yang, Lili
    NATURE PROTOCOLS, 2025,
  • [17] ‘Off-the-shelf’ allogeneic CAR T cells: development and challenges
    S. Depil
    P. Duchateau
    S. A. Grupp
    G. Mufti
    L. Poirot
    Nature Reviews Drug Discovery, 2020, 19 (3) : 185 - 199
  • [18] 'Off-the-shelf' allogeneic CAR T cells: development and challenges
    Depil, S.
    Duchateau, P.
    Grupp, S. A.
    Mufti, G.
    Poirot, L.
    NATURE REVIEWS DRUG DISCOVERY, 2020, 19 (03) : 185 - 199
  • [19] Clinical Pharmacology Considerations for the "Off-the-Shelf" Allogeneic Cell Therapies
    Mody, Hardik
    Sutaria, Dhruvitkumar S.
    Miles, Dale
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 115 (06) : 1233 - 1250
  • [20] Shared neoantigens: ideal targets for off-the-shelf cancer immunotherapy
    Zhao, Wenyi
    Wu, Jingcheng
    Chen, Shuqing
    Zhou, Zhan
    PHARMACOGENOMICS, 2020, 21 (09) : 637 - 645